Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

LYFAX vs. LOGSX: which is better?

Bottom line

LYFAX vs LOGSX: the short answer

LYFAX (AlphaCentric Life Sciences and Healthcare Fund) and LOGSX (Live Oak Health Sciences Fund) are both mutual funds.

But LYFAX is far broader, holding 62 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.

LOGSX is cheaper at 1.04% vs 1.66% — a difference of $62 a year per $10,000 invested.

Over five years, LOGSX returned +8.1% a year vs +4.1% for LYFAX.

LYFAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

LYFAX vs LOGSX side by side

LYFAXLOGSX
TypeMutual fundMutual fund
Fund familyMutualOak Associates
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.66%1.04%
Annual cost per $10k$166$104
10-yr cost on $10k (prospectus)$3,039$1,271
Max front load5.75%—
12b-1 fee0.25%—
1-yr return+20.6%+19.6%
5-yr return (annualized)+4.1%+8.1%
10-yr return (annualized)—+7.3%
Best quarter+27.5%+13.4%
Worst quarter−11.9%−13.1%
Net assets (fund)$46.6M$56.1M
Number of holdings6228
Portfolio turnover107%24%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearLYFAXLOGSXDifference
2025+27.9%+19.6%+8.3%
2024−0.4%+0.2%−0.6%
2023+6.9%+1.2%+5.7%
2022−1.1%+3.7%−4.8%
2021−3.6%+17.5%−21.1%
2020+54.4%+6.0%+48.4%

Source: Fund prospectus bar charts

Holdings overlap

5 of LYFAX's top 25 holdings also appear in LOGSX's top 25.

Shared top holdings
HoldingLYFAXLOGSX
Gilead Sciences Inc5.53%3.50%
Vertex Pharmaceuticals Inc5.33%3.26%
Incyte Corp3.51%3.30%
Jazz Pharmaceuticals Plc1.87%5.77%
Amgen Inc1.83%4.86%

Source: SEC Form N-PORT

LYFAX top 10

  1. Gilead Sciences Inc — 5.53%
  2. Vertex Pharmaceuticals Inc — 5.33%
  3. Astrazeneca Plc — 4.63%
  4. First American Funds Inc — 4.26%
  5. Roivant Sciences Ltd — 3.67%
  6. Argenx Se — 3.59%
  7. Neurocrine Biosciences Inc — 3.51%
  8. Incyte Corp — 3.51%
  9. Axsome Therapeutics Inc — 3.43%
  10. Apogee Therapeutics Inc — 3.28%

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

FAQ

What is the difference between LYFAX and LOGSX?
LYFAX (AlphaCentric Life Sciences and Healthcare Fund) and LOGSX (Live Oak Health Sciences Fund) are both mutual funds. But LYFAX is far broader, holding 62 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
Which is cheaper, LYFAX or LOGSX?
LOGSX has the lower expense ratio (1.04%).
Should I own both LYFAX and LOGSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.